These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25710859)

  • 1. Cross-sectional neurocognitive data do not support a transition from fibrofog to Alzheimer disease in fibromyalgia patients.
    Leavitt F; Katz RS
    J Clin Rheumatol; 2015 Mar; 21(2):81-5. PubMed ID: 25710859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibromyalgia and cognition.
    Glass JM
    J Clin Psychiatry; 2008; 69 Suppl 2():20-4. PubMed ID: 18537459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distraction as a key determinant of impaired memory in patients with fibromyalgia.
    Leavitt F; Katz RS
    J Rheumatol; 2006 Jan; 33(1):127-32. PubMed ID: 16395760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.
    Kravitz HM; Katz RS
    Rheumatol Int; 2015 Jul; 35(7):1115-25. PubMed ID: 25583051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
    Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
    Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
    de Jager CA
    Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects.
    Schönknecht P; Pantel J; Kruse A; Schröder J
    Am J Psychiatry; 2005 Nov; 162(11):2071-7. PubMed ID: 16263846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunction in fibromyalgia: slow access to the mental lexicon.
    Leavitt F; Katz RS
    Psychol Rep; 2014 Dec; 115(3):828-39. PubMed ID: 25539171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition.
    Geerlings MI; Jonker C; Bouter LM; Adèr HJ; Schmand B
    Am J Psychiatry; 1999 Apr; 156(4):531-7. PubMed ID: 10200730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalizing memory recall in fibromyalgia with rehearsal: a distraction-counteracting effect.
    Leavitt F; Katz RS
    Arthritis Rheum; 2009 Jun; 61(6):740-4. PubMed ID: 19479690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of patients with questionable (very mild) Alzheimer's disease: longitudinal profiles of individual subjects' decline.
    Perry RJ; Hodges JR
    Dement Geriatr Cogn Disord; 2000; 11(6):342-9. PubMed ID: 11044780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing "fibrofog": Subjective appraisal, objective performance, and task-related brain activity during a working memory task.
    Walitt B; Čeko M; Khatiwada M; Gracely JL; Rayhan R; VanMeter JW; Gracely RH
    Neuroimage Clin; 2016; 11():173-180. PubMed ID: 26955513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denial of memory deficit in Alzheimer's disease.
    Sevush S; Leve N
    Am J Psychiatry; 1993 May; 150(5):748-51. PubMed ID: 8480820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
    Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
    Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premorbid proneness to distress and episodic memory impairment in Alzheimer's disease.
    Wilson RS; Fleischman DA; Myers RA; Bennett DA; Bienias JL; Gilley DW; Evans DA
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):191-5. PubMed ID: 14742585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease.
    Flicker C; Ferris SH; Reisberg B
    J Geriatr Psychiatry Neurol; 1993; 6(2):84-96. PubMed ID: 8512635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive function in fibromyalgia patients.
    Park DC; Glass JM; Minear M; Crofford LJ
    Arthritis Rheum; 2001 Sep; 44(9):2125-33. PubMed ID: 11592377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.